These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

492 related items for PubMed ID: 22821273

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Long-term prognostic value of cardiac troponin I and T versus creatine kinase-MB mass after cardiac surgery in low-risk patients with stable symptoms.
    Vikenes K, Andersen KS, Melberg T, Farstad M, Nordrehaug JE.
    Am J Cardiol; 2010 Sep 15; 106(6):780-6. PubMed ID: 20816117
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Association of baseline C-reactive protein levels with periprocedural myocardial injury in patients undergoing percutaneous bifurcation intervention: a CACTUS study subanalysis.
    Niccoli G, Sgueglia GA, Latib A, Crea F, Colombo A, CACTUS Study Group.
    Catheter Cardiovasc Interv; 2014 Jan 01; 83(1):E37-44. PubMed ID: 23813627
    [Abstract] [Full Text] [Related]

  • 27. One-year clinical outcomes in patients with chronic renal failure treated by percutaneous coronary intervention with drug-eluting stent.
    Barthelemy O, Helft G, Silvain J, Bellemain-Appaix A, Beygui F, Choussat R, Berman E, Collet JP, Montalescot G, Metzger JP, Le Feuvre C.
    Arch Cardiovasc Dis; 2011 Dec 01; 104(12):604-10. PubMed ID: 22152512
    [Abstract] [Full Text] [Related]

  • 28. Impact of diabetes mellitus on patients with unprotected left main coronary artery lesion disease treated with either percutaneous coronary intervention or coronary-artery bypass grafting.
    Luo Y, Yu X, Chen F, Du X, He J, Gao Y, Zhang X, Zhang Y, Ren X, Lv S, Ma C.
    Coron Artery Dis; 2012 Aug 01; 23(5):322-9. PubMed ID: 22750912
    [Abstract] [Full Text] [Related]

  • 29. Aggressive statin therapy in multicenter and effectiveness for the reduction of intra-myocardial damage caused by non-ST elevation acute coronary syndrome: AMERICA study.
    Hara H, Nakamura M, Yokouchi I, Kimura K, Nemoto N, Ito S, Ono T, Itaya H, Shiba M, Wada M, Iijima R, Yamamoto M, Yamamoto M, Hara H, Takagi T, Asahara T, Mitsuo K, Kobayashi N, Sugi K.
    Ther Adv Cardiovasc Dis; 2009 Oct 01; 3(5):357-65. PubMed ID: 19638365
    [Abstract] [Full Text] [Related]

  • 30. Point-of-care assessment of platelet reactivity after clopidogrel to predict myonecrosis in patients undergoing percutaneous coronary intervention.
    Mangiacapra F, Barbato E, Patti G, Gatto L, Vizzi V, Ricottini E, D'Ambrosio A, Wijns W, Di Sciascio G.
    JACC Cardiovasc Interv; 2010 Mar 01; 3(3):318-23. PubMed ID: 20298992
    [Abstract] [Full Text] [Related]

  • 31. Impact of Periprocedural Myocardial Biomarker Elevation on Mortality Following Elective Percutaneous Coronary Intervention.
    Garcia-Garcia HM, McFadden EP, von Birgelen C, Rademaker-Havinga T, Spitzer E, Kleiman NS, Cohen DJ, Kennedy KF, Camenzind E, Mauri L, Steg PG, Wijns W, Silber S, van Es GA, Serruys PW, Windecker S, Cutlip D, Vranckx P.
    JACC Cardiovasc Interv; 2019 Oct 14; 12(19):1954-1962. PubMed ID: 31601389
    [Abstract] [Full Text] [Related]

  • 32. Prognostic value of creatine kinase-myocardial band isoenzyme elevation following percutaneous coronary intervention: a meta-analysis.
    Jang JS, Jin HY, Seo JS, Yang TH, Kim DK, Kim DS, Cho KI, Kim BH, Je HG, Park YH.
    Catheter Cardiovasc Interv; 2013 May 14; 81(6):959-67. PubMed ID: 22744792
    [Abstract] [Full Text] [Related]

  • 33. Type 4a myocardial infarction: Incidence, risk factors, and long-term outcomes.
    Yang X, Tamez H, Lai C, Ho K, Cutlip D.
    Catheter Cardiovasc Interv; 2017 Apr 14; 89(5):849-856. PubMed ID: 27535209
    [Abstract] [Full Text] [Related]

  • 34. Predictors and prognostic value of myocardial injury during transcatheter aortic valve implantation.
    Yong ZY, Wiegerinck EM, Boerlage-van Dijk K, Koch KT, Vis MM, Bouma BJ, Henriques JP, Cocchieri R, Piek JJ, de Mol BA, Baan J.
    Circ Cardiovasc Interv; 2012 Jun 14; 5(3):415-23. PubMed ID: 22668556
    [Abstract] [Full Text] [Related]

  • 35. Transition from CK-MB to troponin did not improve the 1 year mortality of non-ST elevation acute coronary syndromes.
    Novack V, Jotkowitz AB, Cutlip D, Amit G, Liebermann N, Porath A.
    Postgrad Med J; 2008 Jan 14; 84(987):50-5. PubMed ID: 18230752
    [Abstract] [Full Text] [Related]

  • 36. Prevalence and prognostic significance of preprocedural cardiac troponin elevation among patients with stable coronary artery disease undergoing percutaneous coronary intervention: results from the evaluation of drug eluting stents and ischemic events registry.
    Jeremias A, Kleiman NS, Nassif D, Hsieh WH, Pencina M, Maresh K, Parikh M, Cutlip DE, Waksman R, Goldberg S, Berger PB, Cohen DJ, Evaluation of Drug Eluting Stents and Ischemic Events (EVENT) Registry Investigators.
    Circulation; 2008 Aug 05; 118(6):632-8. PubMed ID: 18645057
    [Abstract] [Full Text] [Related]

  • 37. Impact of angiographic and intravascular ultrasound features on clinical outcome after sirolimus-eluting stent implantation for de-novo lesions in nondiabetic and type 2 diabetic patients.
    Du R, Zhang RY, Zhu ZB, Zhang Q, Hu J, Yang ZK, Yan ZJ, Lv AK, Ding FH, Zhang JS, Shen WF.
    Coron Artery Dis; 2010 May 05; 21(3):175-81. PubMed ID: 20305549
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.